A multicultural group practicing yoga together in a bright studio

Embody vs Ro: GLP-1 Comparison 2026

Embody vs Ro: pricing, medication type, clinical support, and which mid-market GLP-1 patient each program fits. Both programs’ prices verified September 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated September 17, 20264 min read

Quick answer

Ro is a coaching-heavy, brand-name-leaning program; Embody is a more medication-first telehealth experience. Choose Ro if you want behavior-change structure; choose Embody if you want straightforward GLP-1 access.

Side-by-side comparison

Feature	Embody	Ro
Best for	Personalized compounded blends and hands-on support	Brand-name access with a polished telehealth UX
Medication type	Compounded GLP-1 with personalization	Brand-name Wegovy and Zepbound; some compounded options
Pricing model	Monthly subscription, formulation-tiered	Membership + medication; insurance-friendly
Semaglutide price	Compounded, $69/mo (limited-time promo; the offer page shows a 'Was $299' strikethrough and a 'Fall Sale Discount Applied!' banner as of 2026-09-17, with an expired-reading countdown), verified 2026-09-17; confirm current price at checkout	Membership $149/mo ($74/mo on annual prepay, $39 first month applies to the membership); Wegovy pill from $149/mo at the entry dose, rising by dose to $299/mo, billed separately (re-read 2026-08-20 on ro.co/weight-loss/pricing: 'Starting at $149/mo', 'See all dose prices')
Tirzepatide price	Compounded tirzepatide / GLP-1+GIP, $119/mo (flat pricing shown on the verified offer page), verified 2026-09-17; no 'was' comparison price shown for tirzepatide specifically, confirm at signup.	Membership $149/mo ($74/mo on annual prepay, $39 first month applies to the membership); Zepbound KwikPen from $299/mo at the entry dose, rising by dose to $449/mo, billed separately (re-read 2026-08-20 on ro.co/weight-loss/pricing: 'Starting at $299/mo', 'See all dose prices')
Key watchout	Embody's published price is a live time-limited promo with no confirmed standing rate: it changed intra-day on 2026-07-14 ($99/mo AM, '$200 OFF, was $299', to $149/mo PM, '$150 OFF, was $299'), and by 2026-08-21 the same offer URL had dropped further to a new low. We rank it at its current verified purchasable price ($69/mo semaglutide) and label it a promo, confirm the exact cost at checkout. Custom blends also warrant scrutiny on ingredient transparency. Also (found 2026-09-06): the offer page states 'In Nebraska, services are limited to patients 19 years of age or older,' a state-specific age gate on top of the Louisiana exclusion. Worth surfacing if RY ever builds Nebraska-specific copy.	Brand-name medication is expensive without insurance, confirm coverage first
Price checked	Checked by a person September 17, 2026 · an automated check re-read it September 21, 2026	Checked by a person September 5, 2026 · an automated check re-read it September 21, 2026

When to choose Embody

You want a compounded program that personalizes the formulation
You're comfortable evaluating ingredient lists and provider transparency
You'd value bundled adjuncts (anti-nausea, B12, etc.) when offered
You're escalating dose and want a provider that adjusts with you

Check current Embody pricing →

When to choose Ro

You want brand-name Wegovy or Zepbound, not compounded
You have insurance and want help running prior authorization
You value a strong app and ongoing clinical messaging
You're willing to pay a higher all-in price for the brand-name path

Check current Ro pricing →

Full reviews

Frequently asked questions

Is Embody cheaper than Ro?

Embody starts lower on semaglutide (Compounded, $69/mo (limited-time promo; the offer page shows a 'Was $299' strikethrough and a 'Fall Sale Discount Applied!' banner as of 2026-09-17, with an expired-reading countdown), verified 2026-09-17; confirm current price at checkout). Embody starts lower on tirzepatide (Compounded tirzepatide / GLP-1+GIP, $119/mo (flat pricing shown on the verified offer page), verified 2026-09-17; no 'was' comparison price shown for tirzepatide specifically, confirm at signup.). Higher doses can shift the picture, so confirm pricing at the dose you're likely to use long-term.

Which is better for semaglutide or tirzepatide, Embody or Ro?

Embody starts lower on both semaglutide and tirzepatide based on listed entry pricing. That said, the right pick is the program whose support model and formulation match what you actually need.

Are Embody and Ro compounded or brand-name?

Embody offers compounded glp-1 with personalization. Ro offers brand-name wegovy and zepbound; some compounded options. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Embody to Ro?

Yes, switching between Embody and Ro is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Embody and Ro to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like Compounded, $69/mo (limited-time promo; the offer page shows a 'Was $299' strikethrough and a 'Fall Sale Discount Applied!' banner as of 2026-09-17, with an expired-reading countdown), verified 2026-09-17; confirm current price at checkout and Membership $149/mo ($74/mo on annual prepay, $39 first month applies to the membership); Wegovy pill from $149/mo at the entry dose, rising by dose to $299/mo, billed separately (re-read 2026-08-20 on ro.co/weight-loss/pricing: 'Starting at $149/mo', 'See all dose prices') are starting tiers, not your guaranteed long-term cost.